[3rd] Experience of Participating in AVAS Scientific Meeting 2025: Latest Evidence Shows New Insights into Vascular Access Management

In this third installment of our overseas academic conference participation experience, we introduce you to Maine Congress.

In Maine Congress,Important research publications on evidence-based vascular access managementThere were Parallel sessions were held on a wide variety of topics: Acute Care, Prehospital and Emergency Care, Technological Innovation, Chronic Care, Home and Ambulatory Care, Intensive Care, Pediatric and Neonatal, Sustainability and Simulation, Cancer Care, Human Resources Development, Health System Governance, and Infection Control,Program structure covering all areas of the vascular access fieldIt was.

I will pick out a few that I find interesting.

PICNICTest Results


In the PICNIC trial (PMID: 39778170), a multicenter, randomized, controlled trial of 1,098 patients showed that the newPeripherally Inserted Central Catheter (PICC) material and standard polyurethane PICC were compared. Results,No superiority was observed with the new material.Rather, an increased complication rate was observed with chlorhexidine PICC.

Large-scale observational study of catheter infections

In a study of approximately 14,000 peripheral venous catheters over a 17-year period in Queensland, Australia, conducted by the Alliance for Vascular Access Teaching and Research (AVATAR),The incidence of bloodstream infections is 0.41 TP3TThe rate was low, indicating that it was not caused by indigenous skin bacteria as previously assumed. and not by indigenous skin bacteria as previously assumed,Infections caused by gram-negative bacteria are more common than expected.The results of the study revealed that This was an important finding that may have implications for the revision of infection prevention strategies.

Routine exchange policy for peripheral intravenous catheters


There was also discussion about the periodic replacement policy for peripheral intravenous catheters. He proposed a review of the traditional 72-96 hour periodic replacement,Catheters can be safely implanted for at least about 5 days.The findings were presented. He also introduced the "Just Say No, Just in Case" campaign, an initiative to reduce unnecessary catheter insertion,Approximately 501 TP3T of catheters actually inserted were unusedThe problem was also reported as being

MidlineCatheter Terminology Unification


Midline catheters were the subject of a keynote lecture by Dr. Victoria, who introduced the Spanish initiative and discussed the important issue of unifying terminology.The definition of "midline" varies from facility to facility.The lack of uniform standards has been a barrier to research, although there is a distinction between insertion with the catheter tip at the subclavian midline and placement in the axillary region. Through the practical examples in Spain, we reaffirmed that the midline catheter is a catheter that still needs to be developed in spite of its promising usefulness,Need for international standardizationWe also gained a better understanding of the

In the next issue, we will discuss the results of our J-IVCARES member's research presentation that broughtResults Beyond Expectationsand the prospects for the future of the vascular access field in Japan as seen from there.